期刊文献+

脑硬脑膜颞浅动脉血管融通术治疗出血型烟雾病的疗效及其影响因素分析 被引量:16

Efficacy and its influencing factors of encephalo-duro-arterio-synangiosis for treatment of hemorrhagic moyamoya disease
下载PDF
导出
摘要 目的探讨脑硬脑膜颞浅动脉血管融通术(EDAS)治疗出血型烟雾病的疗效及其影响因素。方法回顾性分析85例2002年12月—2011年12月在解放军第三○七医院行双侧EDAS治疗、术后采用DSA随访的出血型烟雾病患者的临床资料。分析项目包括性别、首次手术年龄,术前出血次数、脑代谢情况(正电子发射断层扫描,PET)评估、脑出血类型、是否合并脑缺血症状、烟雾病分期、大脑后动脉是否受累及是否有并发症(高血压、高血脂、高血糖任意一项),这些因素对血管重建效果的影响。结果①对85例(170侧大脑半球)术后6~43个月进行了随访,平均随访时间(13±8)个月。170侧大脑半球血管重建有效率为50.6%(86/170)。2例在随访期发生再出血,DSA显示颅外血管已向颅内大量代偿。②单因素分析显示,随着年龄的增大,EDAS的有效率逐渐降低(P=0.003);出血前有缺血症状(P=0.000 1)、术前脑代谢降低或缺损者(P=0.000 1)及术前多次出血者(P=0.057)血管重建的效果更好。③多因素Logistic回归分析显示,高龄(OR=1.919,95%CI:1.163~3.167,P=0.011)是影响出血型烟雾病患者手术效果的独立危险因素,出血前有缺血症状(OR=0.252,95%CI:0.067~0.952,P=0.042)、脑代谢降低或缺损(OR=0.016,95%CI:0.004~0.060,P=0.000)是影响手术效果的保护性因素。结论年龄越低、出血前有缺血症状、脑代谢障碍者的血管重建效果更好。 Objective To investigate the efficacy and its influencing factors of encephalo-duro-ar- terio-synangiosis (EDAS) in the treatment of hemorrhagic moyamoya disease. Methods The clinical da- ta of 85 patients with hemorrhagic moyamoya disease, who admitted to the 301st Hospital of PLA for bilater- al EDAS treatment and were followed up with DSA after procedure, were analyzed retrospectively. The effects of gender, age at first operation , preoperative bleeding frequency, cerebral glucose metabolism (positron emission tomography [ PET ] ) evaluation, types of intracerebral hemorrhage, having cerebral ischemic symptoms or not, stages of moyamoya disease, affecting posterior cerebral artery or not, having complications ( hypertension, heperlipemia or hyperglycaemia ) or not on the result of revascularization ( DSA evaluation). Results (1)85 patients ( 170 sides) were followed up for 6 to 43 months by DSA after procedure. The mean follow-up time was 13 ± 8 months. The effective rate of revascularization of 170 hemispheres was 50.6% (86/170). Two patients had rebleeding during the follow-up period. DSA showed that the extracranial vessels had large number of intracranial compensation. (2)Univariate analysis showed that the effective rate of EDAS decreased gradually with the increase of age ( P = 0. 003 ). The efficacy of vascu- lar reconstruction was even better in patients who had ischemic symptoms before bleeding ( P = 0. 000 1 ) , preoperative reduced or defective brain metabolism ( P = 0. 000 1 ) and multiple attacks of bleeding before procedure ( P = 0. 057 ). (3) Multivariate logistic regression analysis showed that advanced age ( OR = 1. 919, 95% CI 1. 163 to 3. 167 ;P = 0.011 ) was an independent risk factor for affecting the surgical effect in patients with hemorrhagic moyamoya disease. Having ischemic symptoms before bleeding ( OR = 0. 252, 95% CI O. 067 to O. 952 ; P = O. 042 ) and decreased or defects of cerebral metabolism ( OR = O. 016, 95%CI0. 004 to 0. 060; P = 0. 000) were the protective factors for affecting the surgical effect. Conclusion The younger the age, the patients with ischemie symptoms and cerebral metabolic disturbance before procedure, the better effect of revascularization will obtain.
出处 《中国脑血管病杂志》 CAS 2013年第4期169-173,共5页 Chinese Journal of Cerebrovascular Diseases
基金 国家自然科学基金资助项目(81171083) 解放军第三○七医院创新科研基金重点项目(ZD-2012-04)
关键词 脑底异常血管网病 颅内出血 脑血管重建术 治疗效果 危险因素 Moyamoya disease Intracranial hemorrhage Cerebral revascularization Outcome Risk factors
  • 相关文献

参考文献24

  • 1段炼,咸鹏,杨伟中,史万超,冯捷,宗睿,赵峰,韩聪,张正善,高山,邹丽萍.硬膜动脉血管融通术治疗儿童烟雾病[J].中国临床神经外科杂志,2009,14(1):4-7. 被引量:21
  • 2段炼,李志方,史万超,成鹏,杨伟中,宗睿,冯捷,赵峰,张正善.硬脑膜动脉血管融通术治疗成人烟雾病[J].中华神经外科杂志,2010,26(7):616-619. 被引量:26
  • 3Starke RM, Komotar R J, Hickman ZL, et al. Clinical fea- tures, surgical treatment, and long-term outcome of adult moyamoya patients [ J ] . J Neurosurg, 2009, 111 ( 5 ) : 936-942.
  • 4Hallemeier CL, Rich KM, Grubb RL Jr, et al. Clinical fea- tures and outcome in north American adults with moy- amoya phenomenon [ J ]. Stroke ,2006,37 (6) : 1490-1496.
  • 5Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article [ J ]. J Neurosurg, 2009,111 ( 5 ) : 927-935.
  • 6Kim SK, Cho BK, Phi JH, et al. Pediatric moyamoya dis- ease: An analysis of 410 consecutive cases [ J ]. Ann Neurol, 2010,68( 1 ) :92-101.
  • 7Duan L, Bao XY, Yang WZ, et al. Moyamoya disease in China: its clinical features and outcomes [ J ]. Stroke, 2012,43( 1 ) : 56-60.
  • 8Bao XY, Duan L, Li DS, et al. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China[ J]. Cerebrovasc Dis ,2012,34 (4) :305-313.
  • 9Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ( 'moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis ( Moyamoya Disease) of the Minis- try of Health and Welfare,Japan [J]. Clin Neurol Neuro- surg, 1997,99 Suppl 2 : 238-240.
  • 10欧阳巧洪,段中响,段炼,肖玲,冯捷.^(18)F-FDG脑PET显像评价烟雾病治疗效果的价值[J].中国临床医学影像杂志,2009,20(2):117-118. 被引量:6

二级参考文献88

共引文献93

同被引文献99

  • 1Takeuchik SN. Hypogenesis of bilateral internal carotid arteries [J]. No To Shinkei, 1957,9(9):37- 43.
  • 2Suzuki J, Takaku A. Cerebrovascular " moyamoya " dis ease. Disease showing abnormal net like vessels in base of brain [J]. Arch Neurol,1969,20(3):288- 299.
  • 3Fukui M. Current state of study on moyamoya disease in Japan [J]. Surg Neurol, 1997,47 : 140.
  • 4LEA P. Moyamoya disease and moyamoya syndrome[J]. NEJM,2009, 360(12):1226-1237.
  • 5TRIPATHI P,TRIPATHI V, NAIK R J, et al. Moyamoya cases treated with encephaloduroarteriosynangiosis[J]. Indian Pediatr,2008,44(2): 123-127.
  • 6RYAN RW, CHOWDHARY A, BRITZ GW. Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in Moyamoya disease:A review of the literature[J]. Surg Neurol lnt, 2012, 3(1):72.
  • 7FUKUI M. Guidelines for the diagnosis and treatment ofspontaneous occlusion of the circle of Willis ( 'moyamoya' disease). Research committee on spontaneous occlusion of the circle of Willis (moyamoya disease) of the ministry of health and welfare, Japan[J]. Clin Neurol Neurosurg, 1997, 99(2): 238-240.
  • 8KAINTHDS,CHAUDHRY SA,KAINTH I-IS,et al. Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease[J]. Neurosurgery, 2013,72(3):210-215.
  • 9KAZUMATA K, ITO M, TOKAIRIN K, et al.The frequency of postoperative stroke in moyamoya disease following combined revaseularization:a single-university series and systematic review[J].J Neurosurg,2014,121(3):432-440.
  • 10MOGENSEN MA, KARZMARK P, ZEIFERT PD, et al. Neuroradiologic correlates of cognitive impairment in adult Moyamoya disease[J].AJNR Am J Neuroradiol,2012,33(4):721-725.

引证文献16

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部